Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
SCIENTURE HOLDINGS announced the initiation of supply chain activities by its wholly owned subsidiary Scienture, LLC to manufacture launch quantities of Arbli™ (losartan potassium) Oral Suspension, 10 mg/mL for the intended commercial launch of the ...
read more
Monday, February 05, 2018
SCIEX announced a co-marketing agreement with IROA Technologies.
read more
Thursday, February 27, 2014
Sciformix Corporation, a leading Scientific Process Organization (SPO), has announced its presentation of novel practices in labeling management at the 2nd Annual Pharma Labeling Compliance Conference taking place March 19th-20th in Boston, MA. Bindu...
read more
Wednesday, April 03, 2013
Sciformix Corporation, a world leading Scientific Process Organization (SPO), has announced its premium sponsorship of the 5th annual World Drug Safety Congress, taking place from April 24 - 25, 2013 at the Revere Hotel Boston Common, Boston, USA. ...
read more
Scinai Biopharma Services has appointed Eilon Elmalem as site head of the company’s Yavne CDMO facility, effective June 14, 2026.
read more
Scinai Immunotherapeutics has completed a strategic corporate reorganization that establishes a dedicated contract development and manufacturing organization (CDMO) subsidiary and a leaner research and development operation.
read more
Thursday, December 19, 2024
Scinai Immunotherapeutics Ltd., a biopharmaceutical company focused on developing inflammation and immunology (I&I) biological products and providing CDMO services through its Scinai Bioservices business unit, announced the establishment of a U.S.-...
read more
Scinai Immunotherapeutics Ltd., a biopharmaceutical company specializing in inflammation and immunology (I&I) biological products and in providing CDMO services through its Scinai Bioservices unit, announced that it has entered into a binding option ...
read more
UK-based sterile manufacturing specialist SCM Pharma has bolstered its North American profile with the appointment of a US-based business development manager.
read more
Scorpion Biological Services (Scorpion), a biopharmaceutical contract development and manufacturing organization (CDMO) and contract research organization (CRO), today announced the appointment of Stephan Kutzer, Ph.D. as its Interim Chief Executive ...
read more
Wednesday, April 27, 2022
Biopharmaceutical contract development and manufacturing organization (CDMO) Scorpion Biological Services (Scorpion) today announced a planned development partnership with a private developer, the State of Kansas, and local and university affiliates,...
read more
Tuesday, December 20, 2022
Scorpion Biological Services has changed its name to Scorpius BioManufacturing to reflect the company’s recently expanded manufacturing capabilities and the grand opening of its new biomanufacturing facility in San Antonio in October.
read more
Thursday, November 07, 2024
Scorpius Holdings, Inc. announced a partnership with Celltheon Corporation to provide cell line development services to clients using Celltheon’s proprietary GOLDILOCKS™ transposase-based platform.
read more
Wednesday, March 22, 2023
Scorpius BioManufacturing announced the appointment of Gary Welch as Interim President. With a career spanning more than 30 years in biopharmaceuticals at large manufacturers like AbbVie and biotech innovators like Agensys and CytomX, Gary will lead ...
read more
Scorpius BioManufacturing, a Texas-based biologics contract development and manufacturing organization (CDMO), announced the appointment of Joe Payne as Vice President, Quality and Regulatory Affairs.
read more